ФГБОУ ВО Кировский ГМУ Минздрава России — высшее медицинское учебное заведение в городе Кирове.

During the past decade, Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia" #1 sponsor was "Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Promomed, LLC" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia" #1 collaborator was "Sponsor GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia" are "Coronavirus Infections" (3 trials), "Vaccine" (3 trials), "COVID-19" (2 trials), "Dermatitis, Atopic" (2 trials) and "Generalized Pustular Psoriasis" (2 trials). Many other conditions were trialed in "Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia" in a lesser frequency.

Most popular intervention types in "Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia" are "Drug" (10 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Spesolimab" (2 trials), "Standard of care" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia has several departments that took part in Clinical trials: "Kirov State Medical University, Hospital Therapy Department" - 4 trials